Literature DB >> 9020289

Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis bullosa: case reports and literature review.

K T Bastin1, R A Steeves, M J Richards.   

Abstract

Dystrophic epidermolysis bullosa (DEB) is a debilitating systemic disease frequently associated with biologically aggressive secondary squamous cell carcinomas arising from affected skin or mucosal surfaces. Treatment of these carcinomas with surgery, chemotherapy, or radiation is complicated by inherently poor wound healing. We report on two DEB patients treated with radiation therapy for locally advanced squamous cell carcinoma, and retrospectively analyze 10 DEB patients treated with radiation, reported in the literature. Of the 11 fully available and described case results from radiation therapy, six (54%) patients demonstrated a partial tumor response. All patients receiving > 4,500 cGy developed moist skin desquamation and delayed skin healing. Radiation therapy may be of benefit in palliating DEB patients who have locally advanced carcinoma, but has been associated with enhanced normal tissue toxicity, suggesting a narrow or absent therapeutic index between irradiated carcinoma and skin.

Entities:  

Mesh:

Year:  1997        PMID: 9020289     DOI: 10.1097/00000421-199702000-00012

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  6 in total

1.  Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.

Authors:  B Castelo; D Viñal; R Maseda; L Ostios; D Sánchez; B García-Salvatierra; M J Escámez; L Martínez-Santamaría; M Del Río; M Mora-Rillo; Y Vilches; M J Beato; J C López Gutiérrez; N Romero; C Santos; J Miranda; R de Lucas
Journal:  Clin Transl Oncol       Date:  2019-03-12       Impact factor: 3.405

2.  A Kindler syndrome-associated squamous cell carcinoma treated with radiotherapy.

Authors:  Ademar Caldeira; William Correia Trinca; Thais Pires Flores; Andrea Barleze Costa; Claudio de Sá Brito; Karen Loureiro Weigert; Maryana Schwartzhaupt Matos; Carmela Nicolini; Fernando Mariano Obst
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-10

Review 3.  Unraveling cancer lineage drivers in squamous cell carcinomas.

Authors:  Yinglu Guan; Guan Wang; Danielle Fails; Priyadharsini Nagarajan; Yejing Ge
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

4.  Locally advanced tongue squamous cell carcinoma in epidermolysis simplex bullosa patient: a therapeutic conundrum.

Authors:  W Al Shareef; S Sayed; S Kamel; H Alkaf; A Bahaj; R Amin; A Al Herabi
Journal:  Ann R Coll Surg Engl       Date:  2021-03       Impact factor: 1.951

Review 5.  Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.

Authors:  H Montaudié; C Chiaverini; E Sbidian; A Charlesworth; J-P Lacour
Journal:  Orphanet J Rare Dis       Date:  2016-08-20       Impact factor: 4.123

6.  Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.

Authors:  Susan J Robertson; Elizabeth Orrin; Manpreet K Lakhan; Gavin O'Sullivan; Jessie Felton; Alistair Robson; Danielle T Greenblatt; Catina Bernardis; John A McGrath; Anna E Martinez; Jemima E Mellerio
Journal:  Acta Derm Venereol       Date:  2021-08-24       Impact factor: 3.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.